REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-EU tries to restrict vaccine exports to UK with emergency Brexit rules

Fri, 29th Jan 2021 19:28

* EU triggers emergency Brexit clauses

* EU tries to restrict vaccine exports to UK

* UK seeks urgent answers

* Irish PM expresses concerns to EU chief
(Adds reaction, details)

By Andy Bruce and Kate Holton

LONDON, Jan 29 (Reuters) - The European Union on Friday
sought to restrict exports of COVID-19 vaccines to Northern
Ireland by overriding a part of the post-Brexit deal with
Britain, a steep escalation of the bloc's battle to secure
vaccine supplies.

Northern Ireland First Minister Arlene Foster described as
"an incredible act of hostility" the decision by the EU to
invoke Article 16 of the Northern Irish Protocol, which allows
Britain or the EU to take unilateral action if there is an
unexpected negative effect arising from the agreement.

A spokesman for the British government said senior cabinet
minister Michael Gove had expressed to the EU "concern over a
lack of notification", and said it would be "carefully
considering next steps".

The EU move is designed to prevent the open border between
EU-member Ireland and Northern Ireland from acting as a backdoor
for vaccine supplies into the United Kingdom.

It was not immediately clear if the move to invoke the
article, set out in a document published on Friday, would come
into effect immediately. A link to the document was no longer
working at 2050 GMT.

Article 16 was devised as a last resort to alleviate serious
disruption to trade in Northern Ireland after Brexit.

The EU, whose member states are far behind Israel, Britain
and the United States in rolling out vaccines, is scrambling to
get supplies just as the West's biggest drugmakers slow
deliveries to the bloc due to production problems.

The British-Swedish drugmaker AstraZeneca has been
caught in the crosshairs after it said last week it would fall
short of delivering promised vaccines to the EU by March because
of production problems in Belgium.

That has angered Brussels which has demanded to know why it
cannot divert supplies from its British sites which have been
producing millions of shots for British citizens.

The European Commission has agreed a plan to control exports
of vaccines from the bloc, including to Britain, arguing it
needed to do so to ensure its own supplies.

The Commission said its move to invoke Article 16 was
justified to "avert serious societal difficulties" in EU states
due to a lack of vaccine supply, the document published on
Friday said.

Britain has its own domestic supply chain in place for
AstraZeneca's shot, including rolling it out in Northern
Ireland, but it imports Pfizer's vaccine from a factory in
Belgium.

Ireland's Prime Minister Micheál Martin expressed concern to
EU chief Ursula von der Leyen over the executive's decision.

Northern Ireland's Foster went further. "This is an
incredible act of hostility," she said.

"By triggering Article 16 in this manner, the European Union
has once again shown it is prepared to use Northern Ireland when
it suits their interests but in the most despicable manner –
over the provision of a vaccine which is designed to save
lives."

Britain had threatened to trigger the Article 16 safeguard
measures earlier in the month if there were "serious problems"
in supplying supermarkets in Northern Ireland.
(Reporting by Kate Holton, Andy Bruce and William James;
Editing by Guy Faulconbridge)

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.